Stock listing

VX1 Stock Price, News, Filings & Events — Vertex Pharmaceuticals Incorporated

Selected listing: VX1 · XETR · EUR · DE

The VX1:XETR listing represents Vertex Pharmaceuticals Incorporated, a global biotechnology company focused on developing innovative therapies for serious diseases. The company is known for its advancements in treating cystic fibrosis and has a robust pipeline of drug candidates aimed at various genetic diseases. Recent news highlights Vertex's ongoing clinical trials and collaborations that may enhance its market position. Investors can stay updated on the latest filings and events that could impact the company's growth and performance in the biotechnology sector.

VX1:XETREURDEUpdated July 24, 2026
Vertex Pharmaceuticals Incorporated logo
Ticker
VX1:XETR
Asset type
Stock
Market cap
$121.16B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
XETR
Currency
EUR

Vertex Pharmaceuticals Incorporated VX1:XETR stock context

The VX1:XETR listing represents Vertex Pharmaceuticals Incorporated, a global biotechnology company focused on developing innovative therapies for serious diseases. The company is known for its advancements in treating cystic fibrosis and has a robust pipeline of drug candidates aimed at various genetic diseases. Recent news highlights Vertex's ongoing clinical trials and collaborations that may enhance its market position. Investors can stay updated on the latest filings and events that could impact the company's growth and performance in the biotechnology sector.

Research Vertex Pharmaceuticals Incorporated

Alternate listings